ZA905511B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA905511B
ZA905511B ZA905511A ZA905511A ZA905511B ZA 905511 B ZA905511 B ZA 905511B ZA 905511 A ZA905511 A ZA 905511A ZA 905511 A ZA905511 A ZA 905511A ZA 905511 B ZA905511 B ZA 905511B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA905511A
Other languages
English (en)
Inventor
Andrew Malcolm Creighton
Malcolm Creighton Andrew
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of ZA905511B publication Critical patent/ZA905511B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA905511A 1989-07-13 1990-07-13 Pharmaceutical compositions ZA905511B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916072A GB8916072D0 (en) 1989-07-13 1989-07-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA905511B true ZA905511B (en) 1992-03-25

Family

ID=10660005

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905511A ZA905511B (en) 1989-07-13 1990-07-13 Pharmaceutical compositions

Country Status (8)

Country Link
EP (1) EP0409499A3 (xx)
JP (1) JPH04500690A (xx)
AU (1) AU6047190A (xx)
CA (1) CA2033203A1 (xx)
GB (2) GB8916072D0 (xx)
NZ (1) NZ234459A (xx)
WO (1) WO1991000729A2 (xx)
ZA (1) ZA905511B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642519B2 (en) * 1990-07-04 1993-10-21 Zenyaku Kogyo Kabushiki Kaisha Water-soluble bis-dioxopiperazine derivative
GB9015435D0 (en) * 1990-07-13 1990-08-29 Creighton Andrew M Pharmaceutical compositions
GB9115596D0 (en) * 1991-07-12 1991-09-04 Creighton Andrew M Pharmaceutical compositions
US5760039A (en) * 1991-10-25 1998-06-02 Chiron Corporation Lyophilized composition containing S(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
GB9122677D0 (en) * 1991-10-25 1991-12-11 Eurocetus Bv Process for preparing(s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
GB9124483D0 (en) * 1991-11-18 1992-01-08 Windleshaw Enterprises Ltd Bis(3,5-dioxoalkylpiperazine)derivatives for use in treating intracellular accumulation of metal ions
AU7370594A (en) * 1993-07-23 1995-02-20 Lxr Biotechnology Inc. Methods of treating apoptosis and associated conditions
US6265385B1 (en) * 1996-01-11 2001-07-24 Topo Target Aps Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL273691A (xx) * 1961-01-19 1900-01-01
GB1234935A (en) * 1967-07-03 1971-06-09 Nat Res Dev Piperazine derivatives
DE1967027C3 (de) * 1968-07-02 1978-06-22 National Research Development Corp., London Bis-<33-dioxopiperazino)-alkanverbindungen und Verfahren zu ihrer Herstellung
GB1374979A (en) * 1970-12-21 1974-11-20 Nat Res Dev 3,5-dioxopiperazine derivatives
NL163957C (nl) * 1968-07-02 1980-11-17 Nat Res Dev Werkwijze voor het bereiden van een geneesmiddel tegen kanker, alsmede werkwijze voor het bereiden van een 1,2-di(3,5-dioxopiperazinoalkaanverbinding.
GB1236947A (en) * 1968-08-15 1971-06-23 Ici Ltd Process for the preparation of piperazine derivatives
FR2278324A1 (fr) * 1974-07-18 1976-02-13 Bottu Nouveaux derives du paracetamol
DE2511892A1 (de) * 1975-03-19 1976-10-07 Gruenenthal Chemie Arzneimittel
DE2511891A1 (de) * 1975-03-19 1976-10-07 Gruenenthal Chemie Neue derivate des 2,6-dioxopiperazins, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA2033203A1 (en) 1991-01-14
GB8916072D0 (en) 1989-08-31
AU6047190A (en) 1991-02-06
EP0409499A3 (en) 1991-03-27
GB2235874A (en) 1991-03-20
WO1991000729A2 (en) 1991-01-24
NZ234459A (en) 1992-04-28
JPH04500690A (ja) 1992-02-06
GB9015437D0 (en) 1990-08-29
WO1991000729A3 (en) 1991-06-13
EP0409499A2 (en) 1991-01-23

Similar Documents

Publication Publication Date Title
GB8926612D0 (en) Pharmaceutical compositions
CY1637A (en) Pharmaceutical compositions
GB8904182D0 (en) Pharmaceutical compositions
GB8909022D0 (en) Pharmaceutical compositions
EP0409499A3 (en) Pharmaceutical compositions
GB2232891B (en) Pharmaceutical composition
HUT56269A (en) Pharmaceutical compositions
GB8916071D0 (en) Pharmaceutical compositions
GB8909906D0 (en) Pharmaceutical compositions
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8916069D0 (en) Pharmaceutical compositions
GB8922129D0 (en) Pharmaceutical compositions
GB8917287D0 (en) Pharmaceutical compositions
GB8922149D0 (en) Pharmaceutical compositions
GB8916070D0 (en) Pharmaceutical compositions
GB8902564D0 (en) Pharmaceutical compositions
IE891521L (en) Pharmaceutical compositions
IE892802L (en) Pharmaceutical compositions
IE892803L (en) Pharmaceutical compositions
IE894216L (en) Pharmaceutical compositions
IL89935A0 (en) Pharmaceutical compositions
GB8919130D0 (en) Pharmaceutical compositions
GB8922130D0 (en) Pharmaceutical compositions
GB8915044D0 (en) Pharmaceutical compositions
GB8914099D0 (en) Pharmaceutical compositions